Compile Data Set for Download or QSAR

Found 72 hits of Enzyme Inhibition Constant Data   

TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 5.80nMAssay Description:Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 5.80nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 46nMAssay Description:Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350064(CHEMBL1813435)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350045(CHEMBL1813270)copy SMILEScopy InChI
Affinity DataIC50: 2.80E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350060(CHEMBL1813433)copy SMILEScopy InChI
Affinity DataIC50: 3.50E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350042(CHEMBL1813450)copy SMILEScopy InChI
Affinity DataIC50: 3.90E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350054(CHEMBL1813440)copy SMILEScopy InChI
Affinity DataIC50: 5.20E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350046(CHEMBL1813269)copy SMILEScopy InChI
Affinity DataIC50: 7.10E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350061(CHEMBL1813432)copy SMILEScopy InChI
Affinity DataIC50: 7.40E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50198936((R)-1-butyl-3-((R)-cyclohexyl-hydroxy-methyl)-9-(4...)copy SMILEScopy InChI
Affinity DataIC50: 7.80E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350047(CHEMBL1813459)copy SMILEScopy InChI
Affinity DataIC50: 9.30E+3nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350055(CHEMBL1813439)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+4nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350062(CHEMBL1813447)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350043(CHEMBL1813449)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+4nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350051(CHEMBL1813443)copy SMILEScopy InChI
Affinity DataIC50: 2.30E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350037(CHEMBL1813446)copy SMILEScopy InChI
Affinity DataIC50: 2.30E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350056(CHEMBL1813438)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350064(CHEMBL1813435)copy SMILEScopy InChI
Affinity DataIC50: 2.60E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350043(CHEMBL1813449)copy SMILEScopy InChI
Affinity DataIC50: 2.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Rattus norvegicus)
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Oryctolagus cuniculus)
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350041(CHEMBL1813448)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-X-C chemokine receptor type 4(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at CXCR4 assessed as inhibition of SDF1-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350054(CHEMBL1813440)copy SMILEScopy InChI
Affinity DataIC50: 3.20E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350049(CHEMBL1813454)copy SMILEScopy InChI
Affinity DataIC50: 3.30E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350055(CHEMBL1813439)copy SMILEScopy InChI
Affinity DataIC50: 3.30E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 3.40E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350059(CHEMBL1813434)copy SMILEScopy InChI
Affinity DataIC50: 3.40E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350038(CHEMBL1813451)copy SMILEScopy InChI
Affinity DataIC50: 3.50E+4nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350061(CHEMBL1813432)copy SMILEScopy InChI
Affinity DataIC50: 3.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350044(CHEMBL1813271)copy SMILEScopy InChI
Affinity DataIC50: 3.90E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336346(4-(4-(((R)-1-butyl-3-((S)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 4.40E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350048(CHEMBL1813457)copy SMILEScopy InChI
Affinity DataIC50: 4.60E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350060(CHEMBL1813433)copy SMILEScopy InChI
Affinity DataIC50: 4.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350058(CHEMBL1813436)copy SMILEScopy InChI
Affinity DataIC50: 4.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350063(CHEMBL1813444)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50336348(4-(4-(((S)-1-butyl-3-((S)-cyclohexyl(hydroxy)methy...)copy SMILEScopy InChI
Affinity DataIC50: 5.10E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50198936((R)-1-butyl-3-((R)-cyclohexyl-hydroxy-methyl)-9-(4...)copy SMILEScopy InChI
Affinity DataIC50: 5.30E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350040(CHEMBL1813445)copy SMILEScopy InChI
Affinity DataIC50: 5.90E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350056(CHEMBL1813438)copy SMILEScopy InChI
Affinity DataIC50: 6.60E+4nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350042(CHEMBL1813450)copy SMILEScopy InChI
Affinity DataIC50: 6.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350045(CHEMBL1813270)copy SMILEScopy InChI
Affinity DataIC50: 6.80E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350057(CHEMBL1813437)copy SMILEScopy InChI
Affinity DataIC50: 8.10E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350046(CHEMBL1813269)copy SMILEScopy InChI
Affinity DataIC50: 9.10E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350049(CHEMBL1813454)copy SMILEScopy InChI
Affinity DataIC50: 9.80E+4nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350038(CHEMBL1813451)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+5nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350041(CHEMBL1813448)copy SMILEScopy InChI
Affinity DataIC50: 1.12E+5nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50350053(CHEMBL1813441)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+5nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2H70G5QPubMed
Displayed 1 to 50 (of 72 total ) | Next | Last >>* indicates data uncertainty>20%